Document:

EXECUTION VERSION

AMENDMENT NO. 1 TO
LOAN FINANCING AND SERVICING AGREEMENT, dated as of August 13, 2013 (this “Amendment”),
among TCPC Funding I, LLC, a Delaware limited liability company (the “Borrower”), Wells Fargo Bank, National
Association, as collateral agent and collateral custodian (the “Collateral Agent”), Saratoga Funding Corp.,
LLC, as a conduit lender and as an uncommitted lender (the “Conduit Lender”), Deutsche Bank AG, New York Branch,
as agent for the Lender Groups (the “Agent”) and as a committed lender (the “Committed Lender”)
and Deutsche Bank AG, New York Branch, as administrative agent (the “Administrative Agent”).

WHEREAS, the Borrower,
the Collateral Agent, the Conduit Lender, the Agent, the Committed Lender and the Administrative Agent are party to the Loan Financing
and Servicing Agreement, dated as of May 15, 2013 (as amended, supplemented, amended and restated and otherwise modified from time
to time, the “Loan Agreement”); and

WHEREAS, the Borrower,
the Collateral Agent, the Conduit Lender, the Agent, the Committed Lender and the Administrative Agent have agreed to amend the
Loan Agreement in accordance with the terms and conditions set forth herein.

NOW THEREFORE, in
consideration of the foregoing premises and the mutual agreements contained herein, and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as
follows:

ARTICLE I

Definitions

SECTION 1.1.Defined
Terms. Terms used but not defined herein have the respective meanings given to such terms in the Loan Agreement.

ARTICLE II

Amendments

SECTION 2.1.Amendment
to Section 1.1 of the Loan Agreement. Section 1.1 of the Loan Agreement is hereby amended by deleting each instance of the
words “September 16, 2013” and inserting in lieu thereof “August 13, 2013” in the definition of “Facility
Amount”.

SECTION 2.2.Amendment
to Signature Pages to the Loan Agreement. The signature page of Deutsche Bank AG, New York Branch, as Committed Lender, on
and after August 13, 2013 shall be replaced with its signature page hereto.

    	 

    	 

    

ARTICLE III

Conditions to
Effectiveness

SECTION 3.1.This
Amendment shall become effective as of the date first written above upon the execution and delivery of this Amendment by the Borrower,
the Collateral Agent, the Conduit Lender, the Agent, the Committed Lender and the Administrative Agent.

ARTICLE IV

Miscellaneous

SECTION 4.1.Governing
Law. THIS AMENDMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES UNDER THIS AMENDMENT SHALL BE GOVERNED BY, AND CONSTRUED
AND INTERPRETED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK.

SECTION 4.2.Severability
Clause. In case any provision in this Amendment shall be invalid, illegal or unenforceable, the validity, legality, and enforceability
of the remaining provisions shall not in any way be affected or impaired thereby.

SECTION 4.3.Ratification.
Except as expressly amended and waived hereby, the Loan Agreement is in all respects ratified and confirmed and all the terms,
conditions and provisions thereof shall remain in full force and effect.

SECTION 4.4.Counterparts.
The parties hereto may sign one or more copies of this Amendment in counterparts, all of which together shall constitute one and
the same agreement. Delivery of an executed signature page of this Amendment by facsimile or email transmission shall be effective
as delivery of a manually executed counterpart hereof.

SECTION 4.5.Headings.
The headings of the Articles and Sections in this Amendment are for convenience of reference only and shall not be deemed to alter
or affect the meaning or interpretation of any provisions hereof.

[Signature pages follow]

    	2

    	 

    

IN WITNESS WHEREOF,
the parties hereto have caused this Amendment to be duly executed as of the date first written above.

 

	 	TCPC FUNDING I, LLC, as Borrower
	 	 
	 	By:	 
	 	 	Name:
	 	 	Title:
	 	 	 

 

    	[Signature Page to Amendment No. 1 to Loan Agreement]

    	 

    

 

	 	DEUTSCHE BANK AG, NEW YORK BRANCH, as Administrative Agent
	 	 
	 	By:	 
	 	 	Name:
	 	 	Title:
	 	 	 

 

	 	 
	 	 
	 	By:	 
	 	 	Name:
	 	 	Title:
	 	 	 

 

    	[Signature Page to Amendment No. 1 to Loan Agreement]

    	 

    

 

	 	WELLS FARGO BANK, NATIONAL ASSOCIATION, as Collateral Agent and as Collateral Custodian
	 	 
	 	By:	 
	 	 	Name:
	 	 	Title:
	 	 	 

 

 

    	[Signature Page to Amendment No. 1 to Loan Agreement]

    	 

    

	 	SARATOGA FUNDING Corp., LLC, as Conduit Lender and as Uncommitted Lender
	 	 
	 	By:	 
	 	 	Name:
	 	 	Title:
	 	 	 

 

 

    	[Signature Page to Amendment No. 1 to Loan Agreement]

    	 

    

 

	Commitment: $50,000,000	DEUTSCHE BANK AG, NEW YORK BRANCH, as an Agent and as a Committed Lender
	 	 
	 	By:	 
	 	 	Name:
	 	 	Title:
	 	 	 

\

	 	 
	 	 
	 	By:	 
	 	 	Name:
	 	 	Title:
	 	 	 

 

 

 

    	[Signature Page to Amendment No. 1 to Loan Agreement]EMPLOYMENT AGREEMENT

 

This Employment Agreement (the "Agreement")
is effective as of September 4, 2013, by and between Advaxis, Inc., a Delaware corporation (the "Company"), and
Mark J. Rosenblum ("Executive").

 

WHEREAS, the Company and Executive
desire to enter into this Agreement pursuant to which the Company will employ Executive in the capacity, for the period, and on
the terms and conditions set forth herein;

 

NOW, THEREFORE, in consideration
of the premises and mutual covenants and agreements herein contained, the parties hereby agree as follows:

 

1. EMPLOYMENT AND DUTIES. The Company
hereby employs Executive and Executive hereby accepts such employment in the capacity of Chief Financial Officer ("CFO"),
Senior Vice President and Secretary of the Company to act in accordance with the terms and conditions hereinafter set forth. During
the Term (as defined below), Executive agrees that he will devote time, attention and skills to the operation of the Business (as
defined below) of the Company and that he will perform such duties, functions, responsibilities and authority in connection with
the foregoing as are from time to time delegated to Executive by the Chief Executive Officer as delegated by the Board of Directors
of the Company (the "Board"), which duties shall include but shall not be limited to generating financial statements,
bank reconciliations, schedules of assets and liabilities, and completing and, to the extent required, certifying all financial
and related Securities and Exchange Commission (“SEC”) filings required to be made by the Company, and providing
minutes to all Director meetings. For purposes of this Agreement, the “Business” of the Company shall be defined
as the development and commercialization of immunotherapy drug candidates and related technology based products. Executive is not
bound by the terms of any agreement with any previous employer or other party which would limit his abilities to perform his duties
and obligations hereunder.

 

Executive represents and warrants that he
is not bound by the terms of any agreement with any previous employer or other party which would limit his abilities to perform
his duties and obligations hereunder. In connection with Executive’s employment, Executive further represents and warrants
that he will not use any confidential or proprietary information of any previous employer.

 

2. TERM. The term of this Agreement
shall commence on the date hereof and shall continue for a period of one (1) years (the “Initial Term”). Thereafter,
this Agreement shall be automatically renewed for one year periods (“Renewal Terms”), unless otherwise terminated
by the Company or Executive upon written notice to the other given not less than ninety (90) days prior to the expiration of the
Initial Term or the applicable Renewal Term of the Agreement. The Initial Term and any Renewal Terms thereof shall be referred
to herein as the "Term."

 

3. COMPENSATION. In consideration
of all the services to be rendered by Executive to the Company hereunder, the Company hereby agrees to pay or otherwise provide
Executive the following compensation and benefits. It is furthermore understood that the Company shall have the right to make any
applicable deductions or withholdings as agreed to by the parties or required by applicable law (including but not limited to Social
Security payments, income tax withholding and other required deductions not in effect or which may become effective by law any
time during the Term) from the following compensation.

 

    	 

    	 

    

 

(a) SALARY. Executive shall receive
an annual salary of Two Hundred and Seventy-Five Thousand Dollars ($275,000.00), plus annual cost of living (COLA—as determined
by the Social Security Administration) salary increases commencing on the one-year anniversary of the execution of this Agreement
("Base Salary"). The applicable Base Salary shall be reviewed by the Board immediately following the end of the
Company’s fiscal year to determine the annual increase, or decrease consistent with the Company’s decrease in the base
salaries of other senior executives, to the applicable year’s Base Salary; provided, however, that in no event shall such
annual increase be less than the cost of living increase. The applicable Base Salary will be paid in equal installments not less
frequently than bi-monthly in accordance with the Company's salary payment practices in effect from time to time for senior executives
of the Company. The Compensation Committee of the Board of Directors (the “Compensation Committee”) and the
Executive mutually agree, on or before September 30, 2013, whether to pay a percentage, if any, of the Base Salary in the form
of Advaxis restricted stock unit awards. The percentage, if any, of such award is subject to increase or decrease upon mutual agreement
between Executive and the Compensation Committee.

 

(b) BONUS PAYMENT.

 

(i) In addition to Section 3(b)(ii)
of this Agreement, below, at the end of each fiscal year of the Company, in addition to the Base Salary then in effect, Executive
shall be eligible to receive a bonus payment (the "Bonus Payment") of between 10 and 50% of the applicable year’s
Base Salary (the "Bonus Percentage"). The Bonus Payment, if any, will be paid in accordance with the Company's
bonus payment practices in effect from time to time for senior executives of the Company. It will be awarded in the sole discretion
of the Compensation Committee based on a mutually agreed set of goals established during the first month of each fiscal year. Determinations
as to whether Executive has met these mutually agreed upon set of goals will be determined in the sole discretion of the Compensation
Committee. Executive must be employed by the Company, without the occurrence of any of the Events of Termination, as that term
is defined below, and without having tendered notice to the Company of an anticipated Event of Termination, at the time that the
Bonus Payment is to be paid to Executive.

 

(ii) A one-time payment in an amount to
be determined in the sole discretion of the Compensation Committee on or before September 30, 2013, will be paid to Executive within
two business days following the first instance, subsequent to the execution of this Agreement, in which the Company closes any
financing greater than $15,000,000, so long as such closing occurs during the Initial Term and Executive is still employed by the
Company, without the occurrence of any of the Events of Termination, as that term is defined below, and without having tendered
notice to the Company of an anticipated Event of Termination, at the time that the payment is to be paid to Executive. 50% of such
payment may be made in Advaxis Common Stock, at the Company’s sole discretion.

 

(c) BENEFIT PLANS. As of the date
hereof, Executive shall be eligible to participate in the Company’s group health insurance plan and any other benefit plan
applicable to the Company’s senior executives.

 

    	 

    	 

    

 

(d) INSURANCE. The Company may secure,
in its own name, or otherwise, and at its own expense, life, health, accident and other insurance covering Executive or Executive
and others. Executive agrees to assist the Company in procuring such insurance by submitting to the usual and customary medical
and other examinations and by signing, as the insured, such applications and other instruments in writing as may be reasonably
required by the insurance companies to which application is made pursuant to such insurance. Executive agrees that he shall have
no right, title, or interest in or to any insurance policies or to the proceeds thereof which the Company many so elect to take
out or to continue on the Executive's life.

 

(e) PURCHASE OF COMPANY STOCK.

 

(i) Upon execution and delivery of this
Agreement, Executive will be eligible to receive options to purchase shares of the Company's common stock, par value $.001 per
share (the "Common Stock"), in an amount and at an exercise price determined by the Compensation Committee, which
shall vest in accordance with, and which shall be subject to the restrictions of, the Company's 2011 Omnibus Incentive Plan, a
copy of which is attached hereto as Exhibit A.

 

(ii) Executive shall be permitted to
participate in any capital raise conducted by the Company and purchase shares of Common Stock at a price 15% below the applicable
offering price (or conversion price) of shares offered to investors during such capital raise or offering, consistent with the
Company's 2011 Omnibus Incentive Plan.

 

(f) EXPENSES. Executive shall be
entitled to be reimbursed for all reasonable expenses incurred by him in connection with the fulfillment of his duties hereunder,
including all necessary continuing education and certification costs and related expenses; provided, however, that Executive has
obtained the Company's prior written approval of such expenses and has complied with all policies and procedures related to the
reimbursement of such expenses as shall, from time to time, be established by the Company.

 

(g) VACATIONS AND SICK LEAVE. Executive
shall be entitled to four (4) weeks paid vacation annually to be taken in accordance with the Company's vacation policy in effect
from time to time and at such time or times as may be mutually agreed upon by the Company and Executive. Unused vacation time may
not be carried over from year to year. Executive shall also be entitled to sick leave in accordance with the Company’s sick
leave policies in effect from time-to-time.

 

4. TERMINATION.

 

(a) EVENTS OF TERMINATION. This Agreement
and the employment relationship shall terminate on the earliest to occur of the following events (the “Events of Termination”):

 

(i) expiration of the Term;

 

(ii) written mutual agreement of the Company
and Executive;

 

			(iii) the voluntary resignation by Executive with Good Reason. “Good Reason” shall be defined as: (a) the
failure of the Company to pay Executive any compensation when due, save and except for a disputed claim to compensation; (b) a
significant adverse change in the nature or scope of the authority, powers, functions, responsibilities, or duties attached to
the positions of Executive with the Company as set forth herein; or (c) a material breach by the Company or its successors of a
term or condition of this Agreement.

 

    	 

    	 

    

 

(iv) the voluntary resignation of Executive
without Good Reason;

 

(v) the death of Executive;

 

			(vi) the disability of Executive. Executive shall be deemed disabled if, as a result of
                                                                            Employee’s incapacity due to physical or mental illness, Executive shall have been absent from his duties hereunder
                                                                            on a full time basis for a period of one (1) month or longer;

 

(vii) the retirement of Executive;

 

			(vii) the termination of Executive’s employment by the Company for “Just Cause,” as determined by the Company
in its sole discretion. “Just Cause” shall include: (a) the failure by Executive to substantially perform his
assigned duties for the Company, which failure has continued for a period of at least fifteen (15) days following written notice
of demand for substantial performance, signed by an officer or director of the Company, has been delivered to Executive specifying
the manner in which Executive has failed to substantially perform; (b) Executive engaging in conduct, which in the Company’s
sole discretion, is demonstrably and materially injurious to the Company, which Executive does not cease following Executive’s
receipt of written notice from the Company specifying the nature of such conduct; (c) behavior constituting gross negligence or
willful misconduct by the Executive during the course of his duties and the term of this Agreement; (d) the misappropriation of
corporate assets or corporate opportunities by Executive or any other acts of dishonesty or breach of Executive’s fiduciary
obligation to the Company; or (e) the involvement of Executive in a felony or a misdemeanor involving moral turpitude (including
the entry of a plea of nolo contendre); or

 

(viii) the termination of Executive’s employment by
the Company without “Just Cause.”

 

(b) EVENTS OF TERMINATION TRIGGERING
SEVERANCE PAYMENT. If the Company terminates Executive's employment without Just Cause, if Executive voluntarily resigns with
Good Reason, or if Executive's employment is terminated due to disability, as that term is defined above, Executive shall be entitled
to receive, provided Executive properly executes and does not revoke a Confidential Separation and Release Agreement in the form
provided by the Company at the time of separation from his employment, in addition to the applicable Base Salary, plus any accrued
but unused vacation time and unpaid expenses (in accordance with Sections 3(e) and (f) hereof) that have been earned by the Executive
as of the date of such termination (“Termination Date”), the following severance payments (the "Severance
Payments"):

 

			(i) equal monthly installments at the applicable Base Salary rate then in effect, as determined on the first day of the calendar
month immediately preceding the day of termination, to be paid beginning on the first day of the month following such Termination
Date and continuing twelve (12) months following the Termination Date (the "Severance Period"). Whenever Severance
Payments are payable to Executive hereunder during a time when Executive is partially or totally disabled, and such disability
would entitle him to disability income payments according to the terms of any plan or policy now or hereafter provided by the Company,
the Severance Payments payable to Executive hereunder shall be inclusive of any such disability income and shall not be in addition
thereto, even if such disability income is payable directly to Executive by an insurance company under a policy paid for by the
Company.

 

    	 

    	 

    

 

			(ii) during the Severance Period, health benefits substantially similar to those which Executive was receiving or entitled
to receive immediately prior to termination; provided, however, such insurance benefits shall be reduced to the extent comparable
benefits during such period following Executive's Termination Date, and any benefits actually received by Executive shall be reported
by Executive to the Company.

 

			(iii) all stock options held by the Executive will be deemed fully vested and exercisable on the Termination Date and the exercise
period for such stock options will be increased by a period of two years from the Termination Date.

 

			(iv) issuance of all Common Stock earned by the employee that has not yet been issued within four business days of the Termination
Date.

 

			(v) removal of all restrictive legends on shares held by the Executive that qualify for such treatment under Rule 144 of the
Securities and Exchange Act of 1934 within 10 business days of the presentation of such shares to the Company’s transfer
agent.

 

(c) EVENTS OF TERMINATION NOT TRIGGERING
SEVERANCE PAYMENT. If Executive’s employment with the Company is terminated for any reason other those specifically enumerated
in Section 4(b) of this Agreement, including, but not limited to, the expiration of the Term, written mutual agreement of the Company
and Executive, the voluntary resignation of Executive without Good Reason, the death or retirement of Executive, or the termination
of Executive’s employment by the company with “Just Cause,” Executive shall not be entitled to receive any compensation
other than his accrued salary through the effective date of such termination, plus any accrued but unused vacation time and unpaid
expenses (in accordance with Sections 3(e) and (f) hereof) that have been earned by the Executive as the date of such termination.
Executive shall also be entitled to the continuation of group health plan benefits to the extent authorized by and consistent with
29 U.S.C. § 1161 et seq. (commonly known as “COBRA”), provided, that, Executive shall be solely responsible for
premiums, costs and expenses associated therewith. The provisions of this Section 4(c) shall be in addition to, and not in lieu
of, any other rights and remedies the Company may have at law or in equity under any other provision of this Agreement in respect
of such termination of employment.

 

5. RESTRICTIVE COVENANTS. Executive
and the Company agree that the Company would suffer irreparable harm and incur substantial damage if Executive were to enter into
Competition (as defined herein) with the Company. Therefore, in order for the Company to protect its legitimate business interests,
Executive agrees as follows:

 

(a) Without the prior written consent of
the Company, Executive shall not, during the period of employment with the Company for any reason, directly or indirectly, invest
or engage in any business that is Competitive (as defined herein) with the Business of the Company or accept employment or render
services to a Competitor (as defined herein) of the Company as a director, officer, agent, employee or consultant or solicit or
attempt to solicit or accept business that is Competitive with the Business of the Company, except that Executive may own up to
five percent (5%) of any outstanding class of securities of any company registered under Section 12 of the Securities Exchange
Act of 1934, as amended.

 

    	 

    	 

    

 

(b) Without the prior written consent of
the Company and upon any termination of Executive's employment with the Company for any reason and for a period of twelve (12)
months thereafter, Executive shall not, either directly or indirectly, (i) invest or engage in any business that is Competitive
(as defined herein) with the Business of the Company, except that Executive may own up to five percent (5%) of any outstanding
class of securities of any company registered under Section 12 of the Securities Exchange Act of 1934, as amended; (ii) accept
employment with or render services to a Competitor of the Company as a director, officer, agent, employee or consultant unless
he is serving in a capacity that has no relationship to that portion of the Competitor's business that is Competitive with the
Business of the Company; or (iii) solicit, attempt to solicit or accept business Competitive with the Business of the Company from
any of the customers of the Company at the time of his termination or within twelve (12) months prior thereto or from any person
or entity whose business the Company was soliciting at such time.

 

(c) Upon termination of his employment with
the Company for any reason, and for a period of twelve (12) months thereafter, Executive shall not, either directly or indirectly,
engage, hire, employ or solicit in any manner whatsoever the employment of an employee of the Company.

 

(d) For purposes of this Agreement, a business
or activity is in "Competition" or "Competitive" with the Business of the Company if it involves,
and a person or entity is a "Competitor", if that person or entity is engaged in, or about to become engaged in,
the research, development, design, manufacturing, marketing or selling of a specific product or technology that resembles, competes,
or is designed to compete, with, or has applications similar to any product or technology for which the Company has obtained or
applied for a patent or made disclosures, or any product or technology involving any other proprietary research or development
engaged in or conducted by the Company during the term of Executive's employment with the Company.

 

6. CONFIDENTIALITY. Executive acknowledges
and agrees that all nonpublic information concerning the business of the Company or any of its affiliates including without limitation,
nonpublic information relating to it or its affiliates’ products, customer lists, pricing, trade secrets, patents, business
methods and cost data, business plans, strategies, drawings, designs, nonpublic information regarding product development, marketing
plans, sales plans, manufacturing plans, management organization (including but not limited to nonpublic data and other information
relating to members of the Board, the Company or any of their affiliates or to management of the Company or any of its affiliates),
operating policies or manuals, financial records, design or other nonpublic financial, commercial, business or technical information
(i) relating to the Company or any of its affiliates or (ii) that the Company or any of its affiliates may receive
belonging to suppliers, customers or others who do business with the Company or any of its affiliates (collectively, the “Confidential
Information”) is and shall remain the property of the Company. Executive recognizes and agrees that all of the Confidential
Information, whether developed by Executive or made available to Executive, other than (i) information that is generally known
to the public, (ii) information already properly in Executive’s possession on a non-confidential basis from a source other
than the Company or its affiliates, which source to Executive’s knowledge is not prohibited from disclosing such information
by a legal, contractual or other obligation of confidentiality to the Company or its affiliates, or (iii) information that can
be demonstrated by Executive to have been independently developed by Executive without the benefit of Confidential Information
from the Company or its affiliates, is a unique asset of the business of the Company, the disclosure of which would be damaging
to the Company. Accordingly, Executive agrees to use such Confidential Information only for the benefit of the Company. Executive
agrees that during the Employment Period and until the sixth anniversary of the date of termination or expiration Executive’s
employment with the Company or its affiliates, Executive will not directly or indirectly, disclose to any person or entity any
Confidential Information, other than information described in clauses (i), (ii) and (iii) above, except as may be required in the
ordinary course of business of the Company or as may be required by law or government authority. If disclosure of any Confidential
Information is requested or required by legal process, civil investigative demand, formal or informal governmental investigation
or otherwise, Executive agrees (i) to notify the Company promptly in writing so that the Company may seek a protective order or
other appropriate remedy, and to cooperate fully, as may be reasonably requested by the Company, in the Company’s efforts
to obtain such a protective order or other appropriate remedy, and (ii) shall comply with any such protective order or other remedy
if obtained. Information concerning the business of the Company or any of its affiliates that becomes public as a result of Executive’s
breach of this Section 6 shall be treated as Confidential Information under this Section 6. Notwithstanding any provision herein
to the contrary, Executive may disclose the terms of this Agreement to the extent necessary to enforce its rights under this Agreement.

 

    	 

    	 

    

 

7. WORKS FOR HIRE. Executive acknowledges
and agrees that all services performed for the Company during the Term are provided on a work for hire basis (as that term is used
in the United States Copyright Act), and that Executive has no right, claim or title, and expressly disavows any such right, claim,
or title, to any such work. If, for any reason, the foregoing is ineffective to confirm the absolute, irrevocable and unconditional
ownership by, or rights of, the Company in any materials created by Executive in connection with such services, or if it should
ever be determined that any of such materials are not a “work-made-for-hire” exclusively owned and authored by the
Company, Executive hereby absolutely, irrevocably and unconditionally assigns (or, to the extent such assignment is or may be prohibited
or limited by any applicable law, hereby absolutely, irrevocably and unconditionally licenses, royalty-free) exclusively to the
Company all of such materials, throughout the universe in perpetuity, without condition, exclusion, limitation or reservation.

 

8. NOTICES. Any notice or other communication
required or permitted to be given hereunder shall be in writing and deemed to have been given when delivered in person or when
dispatched by telegram, electronic mail, or electronic facsimile transfer (confirmed in writing by mail, registered or certified,
return receipt requested, postage prepaid, simultaneously dispatched) to the addressees at the addresses specified below.

 

	 	If to Executive: 	Mark J. Rosenblum
	 	 	9200 Santa Fe Trail
	 	 	Celina, TX  75009
	 	 	 
	 	If to the Company:	James Patton
	              	 	Chairman of the Board
	                  	 	Advaxis, Inc.
	                  	 	305 College Road East
	                    	 	Princeton, New Jersey 08540
	 	 	 

 

    	 

    	 

    

 

or to such other address or fax number as either party may
from time to time designate in writing to the other.

 

9. LEGAL REPRESENTATION. Executive
acknowledges that he was advised to consult with, and has had ample opportunity to receive the advice of, independent legal counsel
before executing this Agreement, and that the Company advised Executive to do so and that Executive has fully exercised that opportunity
to the extent he desired. Executive acknowledges that he had ample opportunity to consider this Agreement and to receive an explanation
from such legal counsel of the legal nature, effect, ramifications, and consequences of this Agreement. Executive warrants that
he has carefully read this Agreement, that he understands completely its contents, that he understands the significance, nature,
effect, and consequences of signing it, and that he has agreed to and signed this Agreement knowingly and voluntarily of his own
free will, act, and deed, and for full and sufficient consideration.

 

10. ENTIRE AGREEMENT. This Agreement,
together with Exhibit A, constitutes the entire agreement between the parties hereto relating to the subject matter hereof, and
supersedes all prior agreements and understandings, whether oral or written, with respect to the same. No modification, alteration,
amendment or revision of or supplement to this Agreement shall be valid or effective unless the same is in writing and signed by
both parties hereto.

 

11. GOVERNING LAW. This Agreement
is made and entered into in the State of New Jersey, and shall in all respects be interpreted, enforced, and governed by and continued
and enforced in accordance with the internal substantive laws (and not the laws of choice of laws) of the State of New Jersey applicable
to contracts entered into and to be performed in New Jersey.

 

12. ASSIGNMENT. The rights and obligations
of the parties under this Agreement shall not be assignable without written permission of the other party.

 

13. SEVERABILITY. The invalidity
of any provision of this Agreement under the applicable laws of the State of New Jersey or any other jurisdiction, shall not affect
the other provisions hereby declared to be severable from all other provisions. The intention of the parties, as expressed in any
provision held to be void or ineffective, shall be given such full force and effect as may be permitted by law.

 

14. SURVIVAL. The obligations of
the Company or its successor to pay any Severance Payments required hereunder subsequent to the termination of this Agreement and
the obligations of Executive under Sections 5, 6, and 7 hereof, and all subparts thereof, shall survive the termination of this
Agreement.

 

15. REMEDIES. Executive and the Company
recognize that the services to be rendered under this Agreement by Executive are special, unique, and of extraordinary character,
and that in the event of the breach by Executive of the terms and conditions of Sections 5, 6, and 7 hereof, or any subpart thereof,
the Company shall be entitled, if it so elects, to institute and prosecute proceedings in any court of competent jurisdiction,
to obtain damages for any breach thereof.

 

    	 

    	 

    

 

16. DISPUTE RESOLUTION. Except for
the right of either party to apply to a court of competent jurisdiction for a temporary restraining order, a preliminary injunction,
or other equitable relief to preserve the status quo or prevent irreparable harm, any and all claims, disputes or controversies
arising under, out of, or in connection with the Agreement, including any dispute relating to production, use or commercialization,
which the parties shall be unable to resolve within sixty (60) days, shall be submitted to good faith mediation. The party raising
such dispute shall promptly advise the other party of such claim, dispute or controversy in a writing, which describes in reasonable
detail the nature of such dispute. By not later than five (5) business days after the recipient has received such notice of dispute,
each party shall have selected for itself a representative who shall have the authority to bind such party, and shall additionally
have advised the other party in writing of the name and title of such representative. By not later than ten (10) business days
after the date of such notice of dispute, the party against whom the dispute shall be raised shall select a mediation firm, company,
or agency in New Jersey, or identify an individual mediator(s), and such representatives shall schedule a date with such firm or
mediator(s) for a mediation hearing. The parties shall enter into good faith mediation and shall share the costs equally. If the
representatives of the parties have not been able to resolve the dispute within fifteen (15) business days after such mediation
hearing, the parties shall have the right to pursue any other remedies legally available to resolve such dispute in either the
Courts of the State of New Jersey or in the United States District Court for the District of New Jersey, to whose jurisdiction
for such purposes Company and Executive each hereby irrevocably consents and submits.

 

    	 

    	 

    

 

IN WITNESS WHEREOF, the parties have
executed this Agreement as of the day and year first above written.

 

	 	 	Advaxis, Inc,	 
	 	 	a Delaware corporation	 
	 	 	 	 
	 	By:  	 	 
	 	     	     /s/ Daniel J. O’Connor	 
	 	     	Name: Daniel J. O’Connor	 
	 	     	Title: President and CEO	 
	 	 	 	 
	 	Executive:	 
	 	 	 	 
	 	 	 	 
	 	 	     /s/ Mark J. Rosenblum	 
	 	  	Mark J. Rosenblum	 
	 	 	 	 

 

    	 

    	 

    

   

EXHIBIT A

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00221-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00221-of-00352.parquet"}]]